SCHEMBL12334429

SCHEMBL12334429

CNC(=O)c1ccc(C(=O)Nc2cc3n(n2)CCN3c2ccc3c(c2)CCN(C)C3=O)s1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 3/20 0.33
▸ HRH3 Q9Y5N1 3/20 0.33
▸ GRM5 P41594 1/20 0.33
▸ AOC3 Q16853 2/20 0.31
▸ KDM4E B2RXH2 2/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ RAB9A P51151 2/20 0.31
▸ CCNT1 O60563 1/20 0.31
▸ CDK4 P11802 1/20 0.31
▸ CCNA2 P20248 1/20 0.31
▸ CCND1 P24385 1/20 0.31
▸ CDK2 P24941 1/20 0.31
▸ CCND3 P30281 1/20 0.31
▸ CDK9 P50750 1/20 0.31
▸ CDK6 Q00534 1/20 0.31
▸ PRF1 P14222 1/20 0.31
▸ CYP11B1 P15538 1/20 0.30
▸ CYP11B2 P19099 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12307852 0.93 GRM5 (0.35) GRM5AOC3CCNT1CDK4CCNA2
SCHEMBL12307906 0.93 GRM5 (0.33) GRM5AOC3CCNT1CDK4CCNA2
SCHEMBL12307866 0.92 FLT3 (0.33) GRM5AOC3CCNT1CDK4CCNA2
SCHEMBL12334737 0.91 KCNH2 (0.36) KCNH2HRH3GRM5AOC3KDM4E
SCHEMBL12307917 0.91 KCNH2 (0.32) KCNH2HRH3GRM5AOC3ALDH1A1
SCHEMBL12307824 0.90 NPC1 (0.38) GRM5ALDH1A1RAB9AMEN1KMT2A
SCHEMBL12334298 0.89 POLB (0.34) KCNH2HRH3GRM5AOC3KMT2A
SCHEMBL12307832 0.89 CCNT1 (0.33) KCNH2HRH3GRM5AOC3KDM4E
SCHEMBL12307845 0.88 KDM4E (0.34) GRM5AOC3KDM4EALDH1A1RAB9A
SCHEMBL12307790 0.88 GRM5 (0.32) GRM5AOC3KDM4EALDH1A1PRF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110230472-A1 RING-FUSED AZOLE DERIVATIVE HAVING PI3K-INHIBITING ACTIVITY SHIONOGI & CO., LTD. (JP) 2011-09-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230472-A1 RING-FUSED AZOLE DERIVATIVE HAVING PI3K-INHIBITING ACTIVITY PIK3R5, PIK3R4, PIK3R1 KCNH2 3837/4885HRH3 3328/4885GRM5 1849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback